| | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净占比 散户净流入 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-11-21 | 4.61 | -3.76% | -1389.58万 | -9.12% | 687.76万 | 4.52% | 701.82万 | - 4.61% | | 2025-11-20 | | 4.79 -1.24% | -982.70万 | -16.01% | 504.71万 | 8.22% | 477.99万 | 7.79% | | 2025-11-19 | | 4.85 -1.22% | -345.72万 | -5.09% | -79.97万 | -1.18% | 425.69万 | 6.26% | | 2025-11-18 | 4.91 | -1.01% | -1296.48万 | -16.49% | 131.77万 | 1.68% | 1164.72万 | 14.82% | | 2025-11-17 | 4.96 0.00% | | -257.27万 ...

Core Viewpoint - International Medical (000516) has shown a slight increase in stock price, but the financial performance indicates significant challenges, with declining revenues and profits [1][3]. Financial Performance - As of November 12, 2025, the stock closed at 5.01 CNY, up 1.83% with a trading volume of 464,800 shares and a total transaction value of 231 million CNY [1]. - For the first three quarters of 2025, the company reported a main business revenue of 2.995 billion CNY, a year-on-year decrease of 16.94%, and a net profit attributable to shareholders of -294 million CNY, down 38.45% [3]. - The third quarter alone saw a revenue of 961 million CNY, a decline of 18.95%, and a net profit of -129 million CNY, a staggering drop of 234.24% [3]. Market Position and Ratios - The total market capitalization of International Medical is 11.217 billion CNY, ranking 12th in the medical services industry, which has an average market cap of 19.516 billion CNY [3]. - Key financial ratios include a price-to-earnings ratio of -28.65 and a price-to-book ratio of 3.36, with a gross margin of 6.59%, significantly lower than the industry average of 35.56% [3]. Investment Ratings - In the last 90 days, two institutions have provided ratings for the stock, with one buy rating and one hold rating [4].

Core Viewpoint - International Medical (000516) has shown a decline in stock price and financial performance, indicating potential challenges in the healthcare service sector [1][3]. Financial Performance - As of November 4, 2025, the stock closed at 4.78 yuan, down 0.42% with a trading volume of 139,000 hands and a transaction amount of 66.53 million yuan [1]. - For the first three quarters of 2025, the company's main revenue was 2.995 billion yuan, a year-on-year decrease of 16.94%, and the net profit attributable to shareholders was -294 million yuan, down 38.45% [3]. - The third quarter alone saw a main revenue of 961 million yuan, a decline of 18.95%, and a net profit of -129 million yuan, a staggering drop of 234.24% [3]. Market Position - The total market value of International Medical is 10.702 billion yuan, ranking 12th in the healthcare service industry, which has an average market value of 19.659 billion yuan [3]. - The company has a net asset value of 3.054 billion yuan, ranking 14th in the industry [3]. - The company's gross margin is 6.59%, significantly lower than the industry average of 35.56%, placing it 41st in the industry ranking [3]. Investment Sentiment - In the last 90 days, two institutions have provided ratings for the stock, with one giving a buy rating and another an increase rating [4].

| | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净点比 游资净占比 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-10-27 | 4.89 0.41% | 109.62万 | 1.65% | 109.89万 | 1.66% | -219.50万 | -3.31% | | 2025-10-24 | 4.87 -0.41% | 389.32万 | 8.11% | -66.54万 | -1.39% | -322.79万 | -6.72% | | 2025-10-23 | 4.89 0.20% | 170.77万 | 3.48% | -277.80万 | -5.65% | 107.03万 | 2.18% | | 2025-10-22 | 4.88 0.41% | 443.26万 | 7.37% | -412.30万 | -6.86% | -30.96万 | -0.52% | | 2025-10-21 | 4.86 0.62% | -226.12万 | -3.83% | 260.42万 | 4.42% ...

Core Viewpoint - International Medical (000516) experienced a decline in stock price, closing at 4.91 yuan on October 16, 2025, with a drop of 1.21% and a trading volume of 107,800 hands, resulting in a transaction amount of 53.16 million yuan [1] Financial Performance - The company reported a total revenue of 2.034 billion yuan for the first half of 2025, a year-on-year decrease of 15.95% [3] - The net profit attributable to shareholders was -165 million yuan, an increase of 4.98% year-on-year [3] - The net profit after deducting non-recurring items was -189 million yuan, a decrease of 36.09% year-on-year [3] - In Q2 2025, the company’s revenue was 1.037 billion yuan, down 16.86% year-on-year, while the net profit attributable to shareholders was -58.61 million yuan, up 14.68% year-on-year [3] Market Position and Ratios - The total market capitalization of International Medical is 10.993 billion yuan, ranking 12th in the medical services industry [3] - The company has a net asset value of 3.21 billion yuan, ranking 14th in the industry [3] - The company’s net profit margin is -10.73%, ranking 38th in the industry [3] - The return on equity (ROE) stands at -4.6%, ranking 39th in the industry [3] Recent Trading Activity - On October 16, 2025, the main funds experienced a net outflow of 1.4728 million yuan, accounting for 2.77% of the total transaction amount [1] - Retail investors saw a net outflow of 52,100 yuan, representing 0.1% of the total transaction amount [1] - Over the past five days, the stock has seen fluctuations in net inflows and outflows from different investor categories, indicating varying levels of market interest [2]

证券之星消息，截至2025年8月27日收盘，国际医学(000516)报收于5.34元，下跌3.09%，换手率 2.39%，成交量52.61万手，成交额2.87亿元。 8月27日的资金流向数据方面，主力资金净流出2377.8万元，占总成交额8.29%，游资资金净流入 1903.09万元，占总成交额6.64%，散户资金净流入474.71万元，占总成交额1.66%。 近5日资金流向一览见下表： | | | | 日期 收盘价 涨跌幅 主力净流入 主力净占比 游资净点比 散户净流入 散户净占比 | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 2025-08-27 | 5.34 -3.09% | -2377.80万 | -8.29% | 1903.09万 | 6.64% | 474.71万 | 1.66% | | 2025-08-26 | 5.51 0.00% | -1279.40万 | -8.04% | -101.01万 | -0.63% | 1380.41万 | 8.67% | | 2025-08-25 | 5.51 0.55% | -136 ...